BioZ

CardioDynamics Reports Second Fiscal Quarter 2009 Results

...ing 129 stand alone ICG monitors, 94 of which were bioz Dx systems, 10 bioz monitors, and 25 Medis ICG monitors ICG s...ver year ICG sales decline was driven by 22% lower bioz sales, partially offset by 8% growth in recurring ...

CardioDynamics to Participate in National Health Care Day of Service on June 27th

...heart disease. CDIC will have representatives on site equipped with its ICG bioz Dx(R) monitors to provide free testing and offer educational materials abou...o uncertainties and risks including the Company's primary dependence on the bioz (R) product line, and various uncertainties characteristic of early grow...

CardioDynamics Reports First Quarter 2009 Results

...25 ICG Modules, 133 ICG monitors, 68 of which were bioz Dx(R) systems, 8 BioZ(R) Monitors, and 57 Medis IC...ments, such as the continued success of our C3 and bioz Certified programs, the accuracy of which is neces... including the Company's primary dependence on the bioz product line, and various uncertainties characteri...

CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008

...ales increased 32% to 291 units, 108 of which were bioz Dx systems, 9 bioz monitors, 21 Medis monitors and 153 bioz modules, up from a total of 221 ICG monitors and m...

CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities

...ins forward-looking statements, the accuracy of which is necessarily subject to uncertainties and risks including the Company's sole dependence on the bioz (R) product line, positive growth trends, achievement of cash flow break-even and various uncertainties characteristic of early growth companies, a...

CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 2008

...its, including 137 ICG monitors, 108 of which were bioz Dx systems, 14 bioz monitors, and 15 Medis ICG monitors -- ICG senso... including the Company's primary dependence on the bioz product line, and various uncertainties characteri...

CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting

...d with hypertension and we incorporated the use of bioz ICG to guide antihypertensive therapy selection in... Director for PriMed, initially piloted use of the bioz ICG and found that it significantly improved his a... upon his experience, the group initially included bioz ICG in the Hypertension quality process and measur...

CardioDynamics Reports 22% Revenue Growth in First Quarter 2008

...rom a total of 138 units -- Installed base of bioz monitors and modules increased 12% to over 8,0... a 14% increase in the average unit sales price of bioz monitors compared with the first quarter of 2007. ...52 ICG Modules, 214 ICG monitors, 62 of which were bioz Dx systems, 6...

CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007

...ales increased 11% to 174 units, 100 of which were bioz Dx systems, 16 bioz monitors, and 58 Medis ICG monitors, up from 157 I... medical record (EMR) interface capability for our bioz Dx System -- Commenced landmark PREVENT-HF trial,...

BioZ in Medical Products

BioZ Dx

Description:... The new bioz Dx incorporates the world's most advanced impedance cardiography (ICG) technology and powerful reporting features to quickly and easily provide noninv...
Company:Cardio Dynamics

BioZ in Biological Technology

CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase

... device sales totaled 220 units, 110 of which were bioz Dx systems, 7 bioz monitors, 87 ICG Modules, and 16 Medis ICG monitor... a proportionately greater number of higher priced bioz Dx systems sold during the third quarter of 2008, ...

CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcare's Centricity(R) Electronic Medical Record (EMR) System

...Executive Officer, stated, "We are extremely pleased to release our initial bioz ICG direct EMR interface. EMR is a driving, essential factor in the majorit...for heart failure, shortness of breath and high blood pressure patients." bioz ICG technology presently resides in approximately one out of every six (16%...

CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series

...impedance cardiography (ICG) technology, today announced that the Company's bioz ICG technology is featured in American College of Cardiology's ACCEL audio ...hope it will help further increase awareness of ICG among cardiologists." bioz ICG technology is available in approximately one out of every six (16%) of ...

CardioDynamics Ranked in Deloitte's Technology Fast 50 Program for San Diego

...forward-looking statements, the accuracy of which are necessarily subject to uncertainties and risks including the Company's primary dependence on the bioz product line, and various uncertainties characteristic of early growth companies, as well as other risks detailed in the Company's filings with the SE...

CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility

... medical record (EMR) interface capability for its bioz Dx System. The bioz Dx is the product of a co-development partnership ...y also announced FDA 510(k) clearance for expanded bioz Dx EMR interface capability. By improving medical ...

CardioDynamics Provides 2007 Shareholder Meeting Update

... closing of the transaction, the accuracy of which is necessarily subject to uncertainties and risks including the Company's primary dependence on the bioz product line, and various uncertainties characteristic of early growth companies, as well as other risks detailed in the Company's filings with the SE...